Allervax Ragweed vaccine - ImmuLogicAlternative Names: RagVax
Latest Information Update: 05 Jan 2000
At a glance
- Originator ImmuLogic Pharmaceutical
- Class Allergens; Antiallergics; Plant allergy immunotherapies
- Mechanism of Action Immunomodulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Hypersensitivity
Most Recent Events
- 05 Jan 2000 Discontinued-III for Allergy in USA (Unknown route)
- 05 Jan 2000 Discontinued-Clinical for Allergy in Canada (Unknown route)
- 01 Dec 1997 Investigation in Allergy in Canada (Unknown route)